Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DABIGATRAN ETEXILATE Cause Device occlusion? 10 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Device occlusion have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.0% of all adverse event reports for DABIGATRAN ETEXILATE.

10
Reports of Device occlusion with DABIGATRAN ETEXILATE
0.0%
of all DABIGATRAN ETEXILATE reports
1
Deaths
6
Hospitalizations

How Dangerous Is Device occlusion From DABIGATRAN ETEXILATE?

Of the 10 reports, 1 (10.0%) resulted in death, 6 (60.0%) required hospitalization.

Is Device occlusion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does DABIGATRAN ETEXILATE Cause?

Gastrointestinal haemorrhage (4,081) Cerebrovascular accident (2,175) Fall (1,786) Ischaemic stroke (1,581) Anaemia (1,412) Haemorrhage (1,324) Death (1,025) Rectal haemorrhage (964) Cerebral haemorrhage (946) Upper gastrointestinal haemorrhage (861)

What Other Drugs Cause Device occlusion?

PEGFILGRASTIM (3,239) CARBIDOPA\LEVODOPA (1,464) SOMATROPIN (823) LEUPROLIDE (786) EPOPROSTENOL (580) TREPROSTINIL (458) ALBUTEROL (431) MEDROXYPROGESTERONE (284) BACLOFEN (254) LEVODOPA (224)

Which DABIGATRAN ETEXILATE Alternatives Have Lower Device occlusion Risk?

DABIGATRAN ETEXILATE vs DABRAFENIB DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB DABIGATRAN ETEXILATE vs DACARBAZINE DABIGATRAN ETEXILATE vs DACLATASVIR DABIGATRAN ETEXILATE vs DACLIZUMAB

Related Pages

DABIGATRAN ETEXILATE Full Profile All Device occlusion Reports All Drugs Causing Device occlusion DABIGATRAN ETEXILATE Demographics